Price $79.29 |
Market Cap
23.44B
|
Sector Health Care |
Div. Growth
11.40%
|
|
P/E
22.6
|
P/B
5.06
|
P/S
4.72
|
Dividend %
0.90%
|
|
P/CF
-
|
P/FCF
34.5
|
Op. Cash Flow
1.08M
|
FCF
2.2
|
|
Op. Margin
18.50%
|
Net Margin
21.10%
|
ROE
22.00%
|
ROI
13.60%
|
|
ROA
12.20%
|
EPS Growth
262.70%
|
Current Ratio
3.3
|
Debt/Equity
39.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc (ZBH) | $144.54 | - | 0.70% | 28.38B | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.70 | - | - | 13.1M | Strong Buy |
| Novan Inc (NOVN) | $1.97 | - | - | 57.4M | Strong Buy |
| Natus Medical Inc (NTUS) | $32.15 | - | - | 1.15B | Strong Buy |
| MTBC Inc (MTBC) | $3.86 | - | - | 43.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
